# Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty

> **NCT02713490** · PHASE4 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 140 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** EXPAREL
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT02713490
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-18
- **Primary completion:** 2017-02-08
- **Final completion:** 2017-02-08
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2020-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02713490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02713490, "Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02713490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*